ATS View
한국어

GC Cell KRX:144510KOSDAQ

지씨셀 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h0
Articles, 7 days26
DART filings, 7 days0
Articles tracked26since Sep 11

In Q2 2026, GC Cell reported revenue of ₩41.6bn, down 3.1% year on year, and an operating loss of ₩1.0bn. GC Cell (지씨셀) appeared in 26 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 11 with 25 articles. The most common catalyst was clinical & approvals (5). It was most often mentioned alongside GC Biopharma.

GC Cell quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩41.6bn-3.1%−₩1.0bn₩2.2bn
Q1 2026₩37.4bn-5.5%−₩5.1bn−₩2.9bn
Q4 2025 derived₩38.0bn-10.8%−₩4.3bn−₩244bn
Q3 2025₩45.0bn-0.7%−₩397m−₩2.4bn
Q2 2025₩43.0bn-5.4%−₩3.4bn−₩9.5bn
Q1 2025₩39.5bn-3.7%−₩5.7bn−₩17.9bn
Q4 2024 derived₩42.6bn-18.9%−₩9.3bn−₩69.5bn
Q3 2024₩45.3bn-0.2%−₩2.7bn₩9.9bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

GC Cell top stories 2 weeks, by number of outlets

  1. 1
    [지씨셀] 이뮨셀엘씨주 간이식 후 간암 환자에서 재발 억제 및 생존 개선 확인
    14 outlets · 14 articlesFirst report Sep 11 10:10 뉴스더보이스헬스케어
  2. 2
    지씨셀 이뮨셀엘씨주, 간이식 고위험 간암서 2년 무재발생존율 87.5%
    4 outlets · 4 articlesFirst report Sep 11 10:19 PRESS9Clinical trial
  3. 3
    간이식 후 암 재발률 뚝…지씨셀 '이뮨셀엘씨주' 생존 개선 효과 입증
    2 outlets · 2 articlesFirst report Sep 11 11:32 와이드경제
  4. 4
    지씨셀, '이뮨셀엘씨주' 간이식 후 간암 환자서 전체 생존율 개선 가능성 확인
    1 outlets · 1 articlesFirst report Sep 11 23:24 팍스경제TVClinical trial
  5. 5
    지씨셀, 간이식 후 이뮨셀엘씨주 후향적 연구 발표
    1 outlets · 1 articlesFirst report Sep 12 22:24 메디포뉴스
  6. 6
    지씨셀, 간세포함 환자 이뮨셀엘씨주 안전성·재발 억제·전체생존률 개선
    1 outlets · 1 articlesFirst report Sep 11 11:14 이투데이

Latest GC Cell news Korean headlines